Risks and limits of Haarausfall Check

The MyBody-X hair loss check is a commercial test typically based on selected genetic variants (e.g., AR, SRD5A2, VEGF). However, the scientific evidence for personalized prediction or treatment of hair loss is weak. Many markers come from small association studies or animal data that do not translate to humans. Moreover, lifestyle factors (diet, stress, hormones) are often overlooked. A genetic test cannot replace a medical diagnosis – especially for androgenetic alopecia, which is multifactorial. Results may lead to misinterpretation or unnecessary supplement purchases. Without clinical workup (e.g., iron deficiency, thyroid function), the utility is questionable. The evidence is best classified as 'marketing' or 'unclear', as no robust RCTs or clinical guidelines support the clinical relevance of these tests.